title: Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.
authors.forename: Courtney V
authors.initials: CV
authors.lastname: Fletcher
authors.forename: Jaime G
authors.initials: JG
authors.lastname: DeVille
authors.forename: Pearl M
authors.initials: PM
authors.lastname: Samson
authors.forename: John H
authors.initials: JH
authors.lastname: Moye
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Church
authors.forename: Hans M L
authors.initials: HM
authors.lastname: Spiegel
authors.forename: Paul
authors.initials: P
authors.lastname: Palumbo
authors.forename: Terence
authors.initials: T
authors.lastname: Fenton
authors.forename: M Elizabeth
authors.initials: ME
authors.lastname: Smith
authors.forename: Bobbie
authors.initials: B
authors.lastname: Graham
authors.forename: Joyce M
authors.initials: JM
authors.lastname: Kraimer
authors.forename: William T
authors.initials: WT
authors.lastname: Shearer
mesh_terms: D016860:CD4 Immunoadhesins / Q000008:administration & dosage*; D002648:Child; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008297:Male; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D016860:CD4 Immunoadhesins; C096753:CD4-IgG(2); D011993:Recombinant Fusion Proteins